Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Evelo Biosciences, Inc. EVLO

Full chart Compare
Set alert

Price alert · EVLO

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.0005 Day range 0.0005
0.0001 52-week range 0.0005
YTD
-80.00%
1 year
-80.00%

Financial health

Altman Z-Score

-53.28 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.2×
FY 2016: -3.4×FY 2017: -2.1×FY 2018: -5.3×FY 2019: -1.5×FY 2020: -5.1×FY 2021: -2.6×FY 2022: -1.2×
FY 2016 5y median -2.6× FY 2022
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2016 5y median 0.0× FY 2022
P/B -28.1×
FY 2016: 8.2×FY 2017: 2.0×FY 2018: 2.1×FY 2019: 2.2×FY 2020: 15.7×FY 2021: 37.1×FY 2022: -28.1×
FY 2016 5y median 2.2× FY 2022
P/FCF -1.4×
FY 2016: -3.3×FY 2017: -2.4×FY 2018: -5.4×FY 2019: -1.7×FY 2020: -6.4×FY 2021: -3.3×FY 2022: -1.4×
FY 2016 5y median -3.3× FY 2022
EV/EBITDA -1.3×
FY 2016: 79.8×FY 2017: 37.8×FY 2018: -2.8×FY 2019: -0.9×FY 2020: -5.0×FY 2021: -2.7×FY 2022: -1.3×
FY 2016 5y median -2.7× FY 2022
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2016 5y median 0.0× FY 2022
FCF Yield -72.6%
FY 2016: -30.1%FY 2017: -41.8%FY 2018: -18.5%FY 2019: -57.7%FY 2020: -15.6%FY 2021: -30.6%FY 2022: -72.6%
FY 2016 5y median -30.6% FY 2022

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
ROE 2294.2%
FY 2016: -241.3%FY 2017: -95.4%FY 2018: -39.3%FY 2019: -142.3%FY 2020: -307.3%FY 2021: -1409.7%FY 2022: 2294.2%
FY 2016 5y median -142.3% FY 2022
ROIC -199.7%
FY 2016: -79.8%FY 2017: -68.9%FY 2018: -36.5%FY 2019: -106.4%FY 2020: -126.0%FY 2021: -159.3%FY 2022: -199.7%
FY 2016 5y median -126.0% FY 2022
ROA -177.7%
FY 2016: -71.8%FY 2017: -64.1%FY 2018: -33.7%FY 2019: -94.2%FY 2020: -103.3%FY 2021: -139.0%FY 2022: -177.7%
FY 2016 5y median -103.3% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 FY 2022
Operating Income 6.0%
FY 2016: 0.0%FY 2017: -111.4%FY 2018: -111.0%FY 2019: -48.6%FY 2020: -6.4%FY 2021: -25.6%FY 2022: 6.0%
FY 2016 FY 2022
EPS (diluted) 43.1%
FY 2016: 0.0%FY 2017: -59.0%FY 2018: 67.1%FY 2019: -8.6%FY 2020: 11.3%FY 2021: 2.7%FY 2022: 43.1%
FY 2016 FY 2022
Free Cash Flow -3.7%
FY 2016: 0.0%FY 2017: -84.4%FY 2018: -110.9%FY 2019: -42.2%FY 2020: 0.8%FY 2021: -32.1%FY 2022: -3.7%
FY 2016 FY 2022

Financial Health

Current Ratio 4.2×
FY 2016: 7.0×FY 2017: 10.1×FY 2018: 16.0×FY 2019: 8.0×FY 2020: 3.6×FY 2021: 4.1×FY 2022: 4.2×
FY 2016 5y median 4.2× FY 2022
Quick Ratio 4.2×
FY 2016: 7.0×FY 2017: 10.1×FY 2018: 16.0×FY 2019: 8.0×FY 2020: 3.6×FY 2021: 4.1×FY 2022: 4.2×
FY 2016 5y median 4.2× FY 2022
Debt / Equity -10.2×
FY 2016: 1.8×FY 2017: 0.3×FY 2018: 0.1×FY 2019: 0.3×FY 2020: 1.3×FY 2021: 6.5×FY 2022: -10.2×
FY 2016 5y median 0.3× FY 2022
Net Debt / EBITDA -0.0×
FY 2016: -11.3×FY 2017: -33.9×FY 2018: 2.5×FY 2019: 0.7×FY 2020: 0.3×FY 2021: 0.1×FY 2022: -0.0×
FY 2016 5y median 0.3× FY 2022
Interest Coverage -23.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -37.2×FY 2019: -82.3×FY 2020: -43.6×FY 2021: -31.9×FY 2022: -23.2×
FY 2016 5y median -37.2× FY 2022

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31